Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05655936 · ClinicalTrials.gov registry record · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
A NA study of Obesity and Hypertension, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 454
- Enrollment target
- 1
- Study location
NCT05655936: Recruiting NA study of Obesity and Hypertension, sponsored by University of Pittsburgh.
NCT05655936 is a NA study of Obesity and Hypertension that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 454 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05655936, a NA study of Obesity and Hypertension, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 454 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single site, single-blinded parallel randomized control trial that investigates a multi-level intervention to improve postpartum blood pressure in women with hypertensive disorder pregnancy. The investigators will recruit women diagnosed with a hypertensive disorder of pregnancy, identified between 3rd trimester and 2 weeks post-delivery. The investigators will randomize participants to receive usual care home blood pressure monitoring for 6 weeks versus an intervention of usual care + blood pressure and weight monitoring + a doula trained in heart health. This trial will be conducted in partnership with a local community-based organization, Healthy Start Inc.
Primary Outcome
To test the effectiveness of the postpartum Doula intervention the investigators will evaluate blood pressure and mean arterial pressure (MAP) at 12 months postpartum.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Heart Health Doula Intervention Program
Study Locations (1)
Pennsylvania
- Magee Women's Hospital of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT05655936 shows while recruiting
NCT05655936 is an interventional study that assigns participants to a tested intervention. The registered 454 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (45% lower).
The record links to 10 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05655936 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05655936 about?
NCT05655936 is a clinical study titled "Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial". This is a single site, single-blinded parallel randomized control trial that investigates a multi-level intervention to improve postpartum blood pressure in women with hypertensive disorder pregnancy. The investigators will recruit women diagnosed with a hypertensive disorder of pregnancy, identifie...
What is the current status of trial NCT05655936?
This trial is currently recruiting. It is a NA study. The enrollment target is 454 participants. The study started on 2023-06-29. Estimated completion is 2027-07-01.
What conditions does trial NCT05655936 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Overweight, Preeclampsia, Vascular Diseases.
What interventions are being tested in trial NCT05655936?
The interventions under investigation include: Usual Care (BEHAVIORAL), Heart Health Doula Intervention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05655936?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05655936 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05655936's enrollment target sits among peer trials
454 152nd of 1053 higher than 902 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT06510374 · 454 participants · Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- NCT06935357 · 454 participants · Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- NCT05541016 · 455 participants · Phase 2
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI